medigraphic.com
Boletín Médico del Hospital Infantil de México

2007, Número 1

<< Anterior Siguiente >>

Bol Med Hosp Infant Mex 2007; 64 (1)


Consecuencia de la introducción de nuevos tratamientos en neonatología

Jasso-Gutiérrez L

Idioma: Español
Referencias bibliográficas: 36
Paginas: 59-64
Archivo PDF: 126.21 Kb.


RESUMEN

Se describen, en orden cronológico, 16 ejemplos de las consecuencias que en la historia de la neonatología ha tenido la introducción de nuevas medidas terapéuticas sin un suficiente análisis experimental en cuanto a sus riesgos. En ellos podrá identificarse la no realización de protocolos prospectivos de investigación específicos en neonatos, así como estudios de seguridad de varios de los medicamentos que se relatan. Lo anterior con la finalidad de que el lector reflexione sobre estos hechos, así como el considerar algunas recomendaciones que se mencionan al final.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Blackfan KD, Yaglou CP. The premature infant: a study of the effects of atmospheric conditions on growth and development. Am J Dis Child. 1993; 46: 1175-236.

  2. Bakwin H. Oxygen therapy in premature infants anoxemia. Am J Dis Child. 1923; 25: 157-62.

  3. Wilson JL, Long SB, Howard PJ. Respiration of premature infants: response to variations of oxygen and to increased carbon dioxide in inspired air. Am J Dis Child. 1942; 63: 1080-5.

  4. Davies DP. The first feed of low birth babies: changing attitudes in the twentieth century. Arch Dis Child. 1978; 53: 187-92.

  5. Usher R. The metabolic changes in respiratory distress syndrome of prematurity seen as a failure of somatic compensations for asphyxia. En: Ciba Foundations Symposium on Somatic Satability in the Newly Born. London: Churchil; 1961. p. 92-116.

  6. Committee on Fetus and Newborn. Standards and Recommendations for Hospital Care of Newborn Infants. 2nd ed. Evanston: American Academy of Pediatrics; 1954.

  7. Laurance B. Danger of vitamin-K analogues to newborn. Lancet. 1955; 1: 819.

  8. Committee on Nutrition. Vitamin K compounds and the water-soluble analogues: use in the therapy and prophylaxis in pediatrics. Pediatrics. 1961; 28: 501-7.

  9. Nelson EM. Association of vitamin B6 deficiency with convulsions in infants. Public Health Rep. 1956; 71: 445-8.

  10. May DC. Vitamin B6 in human nutrition: a critique and an object lesson. Pediatrics. 1954; 14: 269-79.

  11. Coursin DB. Vitamin B6 deficiency in infants: a follow-up study. Am J Dis Child. 1955; 90: 344-8.

  12. Rayner W. Cyanosis in newly born children caused by aniline marking ink. BMJ. 1886; 1: 294.

  13. Graubart J, Bloom CJ, Coleman FC, Soloman H. Dye poisoning in the nursery: a review of seventeen cases. JAMA. 1945; 128: 1155-7.

  14. Scott EP, Prince GE, Retondo CC. Dye poisoning in infancy. J Pediatr. 1946; 28: 713-8.

  15. Fisch RO, Berlund EB, Bridge AG, Finley PR, Quie PG, Raile R. Methaemoglobinemia in Hospital nursery. JAMA. 1963; 185: 760-3.

  16. Hjelt K, Lund JT, Scherling B. Methaemoglobinaemia among neonates in a neonatal intensive care unit. Acta Pediatr. 1995; 84: 365-70.

  17. Silverman WA. Retrolental fibroplasia: a modern parable. New York: Gruen & Stratton; 1980. p. 79-81.

  18. O’Dell GB. Studies in kernicterus: I. The protein binding of bilirubin. J Clin Invest. 1959; 38: 823-33.

  19. Brodersen R, Robertson A. Chemmistry of bilirubin and its interaction with albumin. En: Levine RL, Maisels MJ, editores. Hyperbilirubinemia in the newborn. EUA: Report of the 85th Ross Conference of Pediatric Research; 1983. p. 91-8.

  20. Brodersen R, Robertson A. Ceftriaxone binding to human serum albumin: competition with bilirubin. Mol Pharmacol. 1989; 36: 478-83.

  21. Kent SP, Wideman GL. Prophylactic antibiotic therapy in infants born after premature rupture of membranes. JAMA. 1959; 171: 1199-290.

  22. Sutherland JM, Kekker WH. Novobiocin and neonatal hyperbilirubinemia. Am J Dis Child. 1961; 101: 447-9.

  23. Anonymous. Neuropathology in newborn infants bathed with hexachlorophene. MMWR. 1973; 22: 93-4.

  24. Roy S. The chloride depletion syndrome. Adv Pediatr. 1984; 31: 235-57.

  25. Duritz G, Oltorf C. Lactobezoar formation associated with high-density caloric formula. Pediatrics. 1979; 63: 647-9.

  26. Erenberg A, Shaw RD, Yousefzadeth D. Lactobezoar in the low-bith-weigth infant. Pediatrics. 1979; 63: 642-6.

  27. Schreiner RL, Brady MS, Franken EA, Stevens DC, Lemons JA, Gresham EL. Increased incidence of lactobezoars in low birth weight infants. Am J Dis Child. 1979; 133: 936-40.

  28. Brown WI, Buits NR, Gipson HT, Huston RK, Kennaway NG. Fatal benzyl alcohol poisoning in a neonatal intensive care unit. Lancet. 1982; 1: 1250.

  29. Anonymus. Neonatal deaths associated with use of benzyl alcohol – United States. MMWR. 1982; 31: 290-1.

  30. LeBel M, Ferron L, Masson M, Pichette J, Carrier C. Benzyl alcohol metabolism and elimination in neonates. Dev Pharmacol Ther. 1988; 11: 347-56.

  31. Glasgow AM, Boeckx RL, Milleer MK, MacDonald MG, August GP, Goodman SI. Hyperosmolality in small infants due to propylene glycol. Pediatrics. 1983; 72: 353-5.

  32. MacDonald MG, Getson PR, Glasgow AM, Miller MK, Boeckx RL, Johnson EL. Propylene glycol: Increased incidence of seizures in low birth weight infants. Pediatrics. 1987; 79: 622-5.

  33. Karp WB, Robertson AF. Vitamin E in neonatology. Adv Pediatr. 1986; 33: 127-47.

  34. Honein MA, Paulozzi LJ, Himelrigh IM. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: A case report and cohort study. Lancet. 1999; 354: 2101-5.

  35. San Fillippo JA. Infantile hypertrophic pyloric stenosis related to ingestion of erythromycin stolate: a report of five cases. J Pediatr Surg. 1976; 11: 177-80.

  36. Peeters TL. Erythromycin and other macrolide as prokinetic agents. Gastroenterology. 1993; 105: 1886-99.




2020     |     www.medigraphic.com